Abstract |
The concept of prebiotics, probiotics, and symbiotics and their use in different situations of daily clinical practice related to clinical nutrition is reviewed, as well as their role in the treatment/prevention of diarrhea (acute, induced by antibiotics, secondary to radiotherapy), inflammatory bowel disease ( ulcerative colitis and pouchitis), in colonic health ( constipation, irritable bowel), in liver disease (steatosis and minimum encephalopathy), and in intensive care, surgical, and liver transplantation. While their effectiveness for preventing antibiotic-induced diarrhea and pouchitis in ulcerative colitis appears to be shown, additional studies are needed to establish recommendations in most clinical settings. The risk of infection associated to use of probiotics is relatively low; however, there are selected groups of patients in whom they should be used with caution (as jejunum infusion).
|
Authors | Gabriel Olveira, Inmaculada González-Molero |
Journal | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
(Endocrinol Nutr)
Vol. 63
Issue 9
Pg. 482-494
(Nov 2016)
ISSN: 1579-2021 [Electronic] Spain |
Vernacular Title | Actualización de probióticos, prebióticos y simbióticos en nutrición clínica. |
PMID | 27633133
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2016 SEEN. Publicado por Elsevier España, S.L.U. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Dietary Carbohydrates
- Dietary Fiber
- Fatty Acids
- Prebiotics
|
Topics |
- Anti-Bacterial Agents
(adverse effects)
- Colonic Neoplasms
(etiology, prevention & control)
- Dietary Carbohydrates
(metabolism)
- Dietary Fiber
(therapeutic use)
- Digestive System Diseases
(microbiology, therapy)
- Fatty Acids
(metabolism)
- Fermentation
- Gastrointestinal Microbiome
- Humans
- Meta-Analysis as Topic
- Metabolic Diseases
(microbiology, therapy)
- Prebiotics
- Probiotics
- Randomized Controlled Trials as Topic
|